Alibaba Health Information Technology Ltd. has filed an updated list of directors to the Hong Kong Stock Exchange, effective December 15, 2025. The Board is led by Mr. Shen Difan, who serves as both Chief Executive Officer and Chairman, alongside Executive Director Mr. Tu Yanwu. Non-executive Directors include Ms. Huang Jiaojiao and Mr. Xu Haipeng. The Board also comprises three Independent Non-executive Directors: Ms. Huang Yi Fei (Vanessa), Dr. Shao Rong, and Ms. Wu May Yihong. Committee roles were also announced: Mr. Shen Difan chairs the Nomination Committee, while Ms. Wu May Yihong leads the Audit Committee and serves as a member of both the Nomination and Remuneration Committees. Ms. Huang Yi Fei (Vanessa) chairs the Remuneration Committee and is a member of the Audit Committee. Dr. Shao Rong is a member of both the Audit and Nomination Committees, and Ms. Huang Jiaojiao is a member of the Remuneration Committee.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alibaba Health Information Technology Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251215-11956175), on December 15, 2025, and is solely responsible for the information contained therein.
Comments